• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    42 Stocks Moving In Monday's Mid-Day Session

    2/28/22 12:43:43 PM ET
    $AER
    $ALF
    $AMYT
    $AUPH
    Diversified Commercial Services
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AER alert in real time by email

    Gainers

    • Mullen Automotive, Inc. (NASDAQ:MULN) jumped 74.4% to $1.20 after the company reported progress on solid-state polymer battery pack development.
    • Renewable Energy Group, Inc. (NASDAQ:REGI) shares jumped 38.7% to $60.75 after Chevron Corp (NYSE:CVX) announced an agreement to acquire the company.
    • IntriCon Corporation (NASDAQ:IIN) gained 37.3% to $23.91 after the company agreed to be acquired by an affiliate of Altaris Capital Partners for $241 million. IntriCon also posted Q4 EPS of $0.23.
    • NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) climbed 30.5% to $2.01 after gaining around 8% on Friday.
    • First Horizon Corporation (NYSE:FHN) shares climbed 30.4% to $23.80 after TD announced acquisition of the company for $25 per share in cash.
    • Imperial Petroleum Inc. (NASDAQ:IMPP) shares rose 26% to $2.6450 after jumping around 34% on Friday.
    • Everbridge, Inc. (NASDAQ:EVBG) gained 23% to $37.67.
    • Lifeway Foods, Inc. (NASDAQ:LWAY) surged 20% to $6.60.
    • Azure Power Global Limited (NYSE:AZRE) gained 19.9% to $18.76. Azure Power announced change in Board of Directors.
    • NextDecade Corporation (NASDAQ:NEXT) gained 19.4% to $3.3450.
    • Reata Pharmaceuticals, Inc. (NASDAQ:RETA) jumped 19% to $31.30 following narrower-than-expected quarterly loss.
    • Homology Medicines, Inc. (NASDAQ:FIXX) surged 17.7% to $3.25. HC Wainwright & Co. maintained Homology Medicines with a Buy and lowered the price target from $30 to $20.
    • JinkoSolar Holding Co., Ltd. (NYSE:JKS) rose 17.4% to $51.24.
    • TPI Composites, Inc. (NASDAQ:TPIC) gained 17.1% to $13.32. Morgan Stanley downgraded TPI Composites from Overweight to Equal-Weight and lowered the price target from $37 to $21.
    • Elbit Systems Ltd. (NASDAQ:ESLT) rose 15.2% to $205.50.
    • RADA Electronic Industries Ltd. (NASDAQ:RADA) jumped 14.8% to $13.30.
    • Stronghold Digital Mining, Inc. (NASDAQ:SDIG) gained 14.8% to $12.14.
    • Indonesia Energy Corporation Limited (NYSE:INDO) shares rose 14.5% to $13.72 after gaining around 4% on Friday.
    • Maxar Technologies Inc. (NYSE:MAXR) gained 14.1% to $32.76.
    • Gevo, Inc. (NASDAQ:GEVO) jumped 13.4% to $3.5850. Gevo recently reported worse-than-expected Q4 EPS results.
    • Seritage Growth Properties (NYSE:SRG) rose 12.3% to $10.36. Seritage Growth Properties is exploring strategic alternatives including a sale of the company, Bloomberg said.
    • Alfi, Inc. (NASDAQ:ALF) rose 10.7% to $2.2810 after climbing 23% on Friday.
    • Navios Maritime Holdings Inc. (NYSE:NM) rose 7.6% to $4.1299.
    • Mynaric AG (NASDAQ:MYNA) rose 7.5% to $10.70.
    • The Very Good Food Company Inc. (NASDAQ:VGFC) rose 7% to $0.5529 after gaining over 5% on Friday.


    Losers

    • EPAM Systems, Inc. (NYSE:EPAM) dipped 37.8% to $238.04 after the company announced it withdrew Q1 and FY22 guidance due to uncertainties related to the events in Ukraine.
    • Esports Entertainment Group, Inc. (NASDAQ:GMBL) shares fell 34.1% to $0.7645. Esports Entertainment Group priced its underwritten public offering of 15 million shares and accompanying warrants to buy 15 million shares.
    • VEON Ltd. (NASDAQ:VEON) shares fell 29.8% to $0.5649 after the company reported Q4 results.
    • Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) shares dipped 28.9% to $11.55 after the company reported a wider quarterly loss.
    • Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) fell 25.1% to $22.1350 after the company reported it voluntarily withdrew the NDA for sotagliflozin and plans prompt resubmission targeted in early Q2 2022. The company also reported Q4 earnings results.
    • Viatris Inc. (NASDAQ:VTRS) fell 22.4% to $11.28 after the company reported worse-than-expected Q4 sales results and issued FY22 sales guidance below estimates. Biocon Biologics Ltd agreed to acquire Viatris biosimilars assets for up to $3.335 billion in stock and cash.
    • IronNet, Inc. (NYSE:IRNT) dropped 22.2% to $4.75.
    • CinCor Pharma, Inc. (NASDAQ:CINC) dipped 21.5% to $22.35.
    • Amryt Pharma plc (NASDAQ:AMYT) fell 19.6% to $6.53. Amryt Pharma said it received Complete Response Letter from the FDA related to Oleogel-S10 New Drug Application.
    • Lordstown Motors Corp. (NASDAQ:RIDE) dropped 16.6% to $2.6750 as the company reported a fourth-quarter FY21 loss per share of $0.42.
    • Itron, Inc. (NASDAQ:ITRI) fell 14.2% to $46.93 as the company reported a fourth-quarter FY21 revenue decline of 8% year-on-year to $485.6 million, missing the consensus of $505.8 million.
    • Kidpik Corp. (NASDAQ:PIK) dropped 13.8% to $2.11.
    • Cano Health, Inc. (NYSE:CANO) fell 13.3% to $4.5000. Cano Health delayed Q4 earnings release and conference call.
    • Enjoy Technology, Inc. (NASDAQ:ENJY) dropped 12.3% to $3.24.
    • OppFi Inc. (NYSE:OPFI) fell 11.7% to $3.5704 as the company lowered its FY21 forecast. OppFi’s board appointed founder and executive chairman Todd Schwartz as CEO.
    • Inspirato Incorporated (NASDAQ:ISPO) fell 10.4% to $49.20 after jumping 50% on Friday.
    • AerCap Holdings N.V. (NYSE:AER) dropped 9.4% to $56.82. AerCap said it signed lease agreements with Norwegian Air Shuttle ASA for ten new Boeing 737 MAX 8 aircraft and eight Boeing 737-800 NG aircraft.
    Get the next $AER alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AER
    $ALF
    $AMYT
    $AUPH

    CompanyDatePrice TargetRatingAnalyst
    Viatris Inc.
    $VTRS
    2/9/2026$18.00Neutral → Buy
    UBS
    NextDecade Corporation
    $NEXT
    2/6/2026$7.00Overweight
    CapitalOne
    Chevron Corporation
    $CVX
    2/2/2026$160.00 → $168.00Hold
    TD Cowen
    Chevron Corporation
    $CVX
    2/2/2026$180.00Buy → Hold
    HSBC Securities
    Chevron Corporation
    $CVX
    1/20/2026$176.00Neutral → Overweight
    Analyst
    Viatris Inc.
    $VTRS
    1/16/2026$15.00Hold → Buy
    Argus
    EPAM Systems Inc.
    $EPAM
    1/6/2026$220.00Hold
    Truist
    Itron Inc.
    $ITRI
    1/5/2026$130.00Accumulate → Buy
    Johnson Rice
    More analyst ratings

    $AER
    $ALF
    $AMYT
    $AUPH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Invus Global Management, Llc was granted 22,400,000 shares, bought $2,000,001 worth of shares (1,538,462 units at $1.30) and was granted 367,145 units of Series B Convertible Preferred Stock (SEC Form 4)

    4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/4/26 4:25:05 PM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Large owner Hanwha Aerospace Co., Ltd. bought $9,399,378 worth of shares (1,651,971 units at $5.69) (SEC Form 4)

    4 - NextDecade Corp (0001612720) (Issuer)

    12/15/25 7:12:58 PM ET
    $NEXT
    Oil & Gas Production
    Utilities

    Large owner Hanwha Aerospace Co., Ltd. bought $5,742,414 worth of shares (932,598 units at $6.16) (SEC Form 4)

    4 - NextDecade Corp (0001612720) (Issuer)

    12/10/25 8:15:10 PM ET
    $NEXT
    Oil & Gas Production
    Utilities

    $AER
    $ALF
    $AMYT
    $AUPH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Yakira Capital Management, Inc. sold $153,761 worth of 7.00% Series A Cumulative Redeemable Preferred Shares (6,380 units at $24.10) (SEC Form 4)

    4 - Seritage Growth Properties (0001628063) (Issuer)

    2/9/26 5:07:57 PM ET
    $SRG
    Real Estate
    Finance

    SEC Form 4 filed by Controller Knowles Alana K

    4 - CHEVRON CORP (0000093410) (Issuer)

    2/6/26 4:51:04 PM ET
    $CVX
    Integrated oil Companies
    Energy

    President, DM&C Walz Andrew Benjamin exercised 22,200 shares at a strike of $117.15 and sold $3,919,050 worth of shares (22,200 units at $176.53) (SEC Form 4)

    4 - CHEVRON CORP (0000093410) (Issuer)

    2/5/26 6:18:18 PM ET
    $CVX
    Integrated oil Companies
    Energy

    $AER
    $ALF
    $AMYT
    $AUPH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $AER
    $ALF
    $AMYT
    $AUPH
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    NeuroSense Expands Global IP Protection Strategy With Granted Australian Patent Covering PrimeC Composition

    Strengthens Global IP Portfolio for PrimeC Through 2042 CAMBRIDGE, Mass., Feb. 9, 2026 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) ("NeuroSense"), a late-clinical stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced that the Australian Patent Office (IP Australia) has granted Australian Patent No. 2022370513, entitled "Compositions Comprising Ciprofloxacin and Celecoxib," representing another strategic step in the continued expansion of the Company's global intellectual property protection for PrimeC. The granted Australian patent, following prior approval of the corresponding U.S. patent (12,097,185), further expands 

    2/9/26 9:20:00 AM ET
    $NRSN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Imperial Petroleum Announces $10 Million Share Repurchase Program

    ATHENS, Greece, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Imperial Petroleum Inc. (NASDAQ:IMPP) (the "Company") today announced that its Board of Directors has approved a share repurchase program and authorized the officers of the Company to repurchase, from time to time, up to $10,000,000 of the Company's common stock. Shares may be purchased in open market or privately negotiated transactions, at times and prices that are considered to be appropriate by the Company, and the program may be suspended or discontinued at any time. About Imperial Petroleum Inc. IMPERIAL PETROLEUM INC. is a ship-owning company providing petroleum products, crude oil and drybulk seaborne transportation services. The

    2/9/26 9:20:00 AM ET
    $IMPP
    Marine Transportation
    Consumer Discretionary

    VEON and JazzWorld Launch "Invest in Pakistan, NOW!" Inviting International Investors to Participate in Pakistan's Growth

    Dubai, New York and Islamabad, 8 February 2026: VEON Ltd. (NASDAQ:VEON), a global digital operator ("VEON" or the "Group"), today announced the launching of its "Invest in Pakistan, NOW!" initiative in partnership with JazzWorld, VEON's services company in Pakistan, during World Governments Summit in Dubai, UAE. "Invest in Pakistan, NOW!" invites international investors to take a fresh look at Pakistan as the country's economic fundamentals strengthen, and long-term growth opportunities become more visible. As a part of the initiative, JazzWorld and Nutshell Group of Pakistan, signed a Memorandum of Understanding (MoU) to advance dialogue and partnerships around digitalization, inclusive gr

    2/8/26 5:00:00 AM ET
    $VEON
    Telecommunications Equipment
    Telecommunications

    FDA Approval for INPEFA issued to LEXICON PHARMACEUTICALS INC

    Submission status for LEXICON PHARMACEUTICALS INC's drug INPEFA (ORIG-1) with active ingredient SOTAGLIFLOZIN has changed to 'Approval' on 05/26/2023. Application Category: NDA, Application Number: 216203, Application Classification: Type 1 - New Molecular Entity

    5/30/23 10:02:49 AM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for SKYCLARYS issued to REATA PHARMACEUTICALS INC

    Submission status for REATA PHARMACEUTICALS INC's drug SKYCLARYS (ORIG-1) with active ingredient OMAVELOXOLONE has changed to 'Approval' on 02/28/2023. Application Category: NDA, Application Number: 216718, Application Classification: Type 1 - New Molecular Entity

    2/28/23 5:14:09 PM ET
    $RETA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for LUPKYNIS

    Submission status for AURINIA PHARMACEUTICALS, INC.'s drug LUPKYNIS (ORIG-1) with active ingredient VOCLOSPORIN has changed to 'Approval' on 01/22/2021. Application Category: NDA, Application Number: 213716, Application Classification: Type 1 - New Molecular Entity

    1/25/21 11:31:10 AM ET
    $AUPH
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AER
    $ALF
    $AMYT
    $AUPH
    SEC Filings

    View All

    SEC Form 6-K filed by NeuroSense Therapeutics Ltd.

    6-K - NeuroSense Therapeutics Ltd. (0001875091) (Filer)

    2/9/26 9:30:05 AM ET
    $NRSN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Imperial Petroleum Inc.

    6-K - Imperial Petroleum Inc./Marshall Islands (0001876581) (Filer)

    2/9/26 9:23:26 AM ET
    $IMPP
    Marine Transportation
    Consumer Discretionary

    SEC Form FWP filed by Lexicon Pharmaceuticals Inc.

    FWP - LEXICON PHARMACEUTICALS, INC. (0001062822) (Subject)

    2/6/26 5:17:30 PM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AER
    $ALF
    $AMYT
    $AUPH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Viatris upgraded by UBS with a new price target

    UBS upgraded Viatris from Neutral to Buy and set a new price target of $18.00

    2/9/26 6:59:24 AM ET
    $VTRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CapitalOne initiated coverage on NextDecade with a new price target

    CapitalOne initiated coverage of NextDecade with a rating of Overweight and set a new price target of $7.00

    2/6/26 8:35:07 AM ET
    $NEXT
    Oil & Gas Production
    Utilities

    TD Cowen reiterated coverage on Chevron with a new price target

    TD Cowen reiterated coverage of Chevron with a rating of Hold and set a new price target of $168.00 from $160.00 previously

    2/2/26 7:18:00 AM ET
    $CVX
    Integrated oil Companies
    Energy

    $AER
    $ALF
    $AMYT
    $AUPH
    Leadership Updates

    Live Leadership Updates

    View All

    Viatris Appoints Matthew J. Maletta as Chief Legal Officer

    Brian Roman to Leave the Company After More Than 20 Years of Exemplary Service; Will Remain Advisor Through Transition Period  PITTSBURGH, Feb. 3, 2026 /PRNewswire/ -- Viatris Inc. (NASDAQ:VTRS) announced today that Matthew J. Maletta has been appointed Chief Legal Officer (CLO), effective February 9, 2026. The appointment follows the transition of the Company's current CLO, Brian Roman, after more than 20 years of exemplary service to Viatris and its predecessor company, Mylan. Roman, who has served in multiple leadership positions and played a key role in supporting the Company's operations, portfolio and growth initiatives, will stay on through April 1, 2026, to ensure a smooth transition

    2/3/26 8:30:00 AM ET
    $VTRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    EPAM to Host Investor Day on March 12, 2026

    Sharing Long-Term Growth Strategy for the Next Wave of AI-Driven Business Transformation NEWTOWN, Pa., Jan. 13, 2026 /PRNewswire/ -- EPAM Systems, Inc. (NYSE: EPAM), a leading digital and AI transformation company, will host an Investor Day in Boston on March 12, 2026. The event will feature remarks by EPAM's Chief Executive Officer and President, Balazs Fejes, and Chief Financial Officer, Jason Peterson, as well as other members of the executive leadership team. "Our Investor Day is an opportunity to demonstrate the solid progress we've made against our long-term strategic pr

    1/13/26 8:02:00 AM ET
    $EPAM
    EDP Services
    Technology

    Melissa Xides Appointed Exclusive Resorts President

    Former Bergdorf Goodman executive joins to strengthen a more private, relationship-led Club for a discerning global Membership Exclusive Resorts today announced the appointment of Melissa Xides as President, signaling a new chapter for the Members-only luxury club following a sustained period of growth and the recent launch of The Exclusive Collective, uniting three market-leading brands to form one of the most expansive private networks in luxury hospitality. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260113869302/en/Melissa Xides, President - Exclusive Resorts After more than six years of expansion across the Club's $1 b

    1/13/26 8:00:00 AM ET
    $ISPO
    Blank Checks
    Finance

    $AER
    $ALF
    $AMYT
    $AUPH
    Financials

    Live finance-specific insights

    View All

    AerCap Holdings N.V. Reports Record Financial Results for the Full Year 2025

    Net income of $633 million, or $3.79 per share, for the fourth quarter of 2025 and $3.8 billion, or $21.30 per share, for the full year 2025. Adjusted net income of $660 million, or $3.95 per share, for the fourth quarter of 2025 and $2.7 billion, or $15.37 per share, for the full year 2025.Quarterly dividend increased to $0.40 per share.DUBLIN, Feb. 6, 2026 /PRNewswire/ -- AerCap Holdings N.V. (NYSE:AER), the industry leader across all areas of aviation leasing, today reported strong financial results for the fourth quarter and full year ended December 31, 2025. "We are pleased to announce another strong quarter for AerCap, completing a year of record net income and earnings per share. Thes

    2/6/26 7:00:00 AM ET
    $AER
    Diversified Commercial Services
    Consumer Discretionary

    Viatris to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026, and Host Investor Event on March 19, 2026

    PITTSBURGH, Feb. 3, 2026 /PRNewswire/ -- Viatris Inc. (NASDAQ:VTRS), a global healthcare company, today announced it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026. Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results. Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website. In addition, Viatris will host an Investor Event on March 19, 2026, in New York City. More details regarding the event will be provided during the Co

    2/3/26 4:34:00 PM ET
    $VTRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chevron Reports Fourth Quarter 2025 Results

    Reported earnings of $2.8 billion; adjusted earnings of $3.0 billion Cash flow from operations of $10.8 billion; adjusted free cash flow of $4.2 billion Increased 2025 worldwide and U.S. production by 12 and 16 percent to record levels Reserve replacement ratio of 158 percent in 2025 Announces a 4 percent increase in quarterly dividend to $1.78 per share Chevron Corporation (NYSE:CVX) reported earnings of $2.8 billion ($1.39 per share - diluted) for fourth quarter 2025, compared with $3.2 billion ($1.84 per share - diluted) in fourth quarter 2024. Included in the quarter was a net loss of $128 million due to pension settlement costs. Foreign currency effects decreased earnin

    1/30/26 6:15:00 AM ET
    $CVX
    Integrated oil Companies
    Energy

    $AER
    $ALF
    $AMYT
    $AUPH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Lexicon Pharmaceuticals Inc.

    SC 13D/A - LEXICON PHARMACEUTICALS, INC. (0001062822) (Subject)

    12/9/24 9:33:20 PM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by NeuroSense Therapeutics Ltd.

    SC 13G - NeuroSense Therapeutics Ltd. (0001875091) (Subject)

    12/9/24 4:00:18 PM ET
    $NRSN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Lifeway Foods Inc.

    SC 13D/A - Lifeway Foods, Inc. (0000814586) (Subject)

    11/15/24 4:33:49 PM ET
    $LWAY
    Packaged Foods
    Consumer Staples